**Latest issues can only be accessed via our mailing list. Join now to stay up to date**

In this issue:

  • Treatment algorithms for androgenetic alopecia

  • Is MTX drug survival increased with SC MTX vs Oral?

  • What are the main skin features of Still’s Disease?

  • GLP-1 receptor agonists and hair loss

  • Metformin and doxycycline for HS: an RCT

  • Identifying patients at high risk of myeloproliferative disorders in aquagenic pruritus

October 2025 issue